Laura K. Nolden

An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

Katherine Stemke‐Hale, Ana M. González-Angulo, Aňa Lluch et al. · Cancer Research · 2008 · 1K citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale et al. · Cancer Research · 2009 · 857 citations · Full text

Medicine, Cancer Biology, Oncology +17

Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer

Astrid Eder, Xiaomei Sui, Daniel Rosen et al. · Proceedings of the National Academy of Sciences · 2005 · 238 citations · Full text

Medicine, Molecular Biology, Oncology +17

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges

Doris R. Siwak, Mark Carey, Bryan T. Hennessy et al. · Journal of Oncology · 2009 · 145 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synergistic induction of apoptosis by the Bcl‐2 inhibitor ABT‐737 and imatinib mesylate in gastrointestinal stromal tumor cells

David Reynoso, Laura K. Nolden, Dan Yang et al. · Molecular Oncology · 2010 · 29 citations · Full text

Life Sciences, Oncology, Pharmacology +17